| LXRX Stock | | | USD 0.80 0.02 2.44% |
Lexicon Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Lexicon Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexicon Pharmaceuticals is a good investment. Please check the relationship between Lexicon Pharmaceuticals Gross Profit and its Other Operating Expenses accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.
Gross Profit vs Other Operating Expenses
Gross Profit vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexicon Pharmaceuticals Gross Profit account and
Other Operating Expenses. At this time, the significance of the direction appears to have weak relationship.
The correlation between Lexicon Pharmaceuticals' Gross Profit and Other Operating Expenses is 0.32. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Lexicon Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Lexicon Pharmaceuticals' Gross Profit and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Lexicon Pharmaceuticals are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Gross Profit i.e., Lexicon Pharmaceuticals' Gross Profit and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.32 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Lexicon Pharmaceuticals minus its cost of goods sold. It is profit before Lexicon Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Lexicon Pharmaceuticals. It is also known as Lexicon Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Lexicon Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexicon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Lexicon Stock please use our
How to Invest in Lexicon Pharmaceuticals guide.At this time, Lexicon Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is likely to rise to about 145.7
M in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(2.71) in 2024.
Lexicon Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Lexicon Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexicon Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexicon Stock Analysis
When running Lexicon Pharmaceuticals' price analysis, check to
measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.